Dendritic and axonal mechanisms of Ca2+ elevation impair BDNF transport in Aβ oligomer–treated hippocampal neurons

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

The mechanism of action of cyclosporin A and FK506

Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127 · see citing works

Culturing hippocampal neurons

Kaech, S., & Banker, G. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.356 · Cited by 1,705 · see citing works

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

Ittner, L. M., & Götz, J. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2967 · Cited by 1,357 · see citing works

The GSK3 hypothesis of Alzheimer’s disease

Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · see citing works

Culturing hippocampal neurons.

Tanaka, H. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.119.163 · Cited by 1,141 · see citing works

Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine

De Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · see citing works

Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

Jin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876 · see citing works

The Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility

Wang, X., & Schwarz, T. L. (2009) · Cell · doi:10.1016/j.cell.2008.11.046 · Cited by 871 · see citing works

Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits.

Hell, J. W., Westenbroek, R. E., Warner, C., Ahlijanian, M. K., Prystay, W., Gilbert, M., Snutch, T. P., & Catterall, W. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.4.949 · Cited by 760 · see citing works

Axonal transport deficits and neurodegenerative diseases

Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755 · cited 2× · see citing works

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

Lu, B., Nagappan, G., Guan, X.-M., Nathan, P. J., & Wren, P. B. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3505 · Cited by 747 · see citing works

Aβ Oligomers Cause Localized Ca ²⁺ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2357-10.2010 · Cited by 686 · cited 2× · see citing works

The stress of dieting

Hutchinson, E. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2985 · Cited by 534 · see citing works

Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486 · see citing works

Measuring calcium signaling using genetically targetable fluorescent indicators

Palmer, A. E., & Tsien, R. Y. (2006) · Nature Protocols · doi:10.1038/nprot.2006.172 · Cited by 463 · see citing works

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 3× · see citing works

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., Bigio, E. H., Jerecic, J., Acton, P. J., Shughrue, P. J., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.029 · Cited by 432 · see citing works

Calcium Signaling and Amyloid Toxicity in Alzheimer Disease

Demuro, A., Parker, I., & Stutzmann, G. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.080895 · Cited by 409 · see citing works

Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility

Morfini, G. A., Szebenyi, G., Elluru, R. G., Ratner, N., & Brady, S. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.281 · Cited by 399 · see citing works

Calcium hypothesis of Alzheimer’s disease

Berridge, M. J. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0736-1 · Cited by 384 · see citing works

Calcium channel auxiliary α2δ and β subunits: trafficking and one step beyond

DOLPHIN, A. C. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3311 · Cited by 369 · see citing works

Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases

Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335 · see citing works

Monoclonal antibodies that target pathological assemblies of Aβ

Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04157.x · Cited by 314 · see citing works

Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport

Pigino, G. F., Morfini, G. A., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 300 · see citing works

Syntaxin-4 defines a domain for activity-dependent exocytosis in dendritic spines

Kennedy, M. J., Davison, I. G., Robinson, C. G., & Ehlers, M. D. (2010) · Cell · doi:10.1016/j.cell.2010.02.042 · Cited by 294 · see citing works

Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease

Oulès, B., Prete, D. D., Greco, B., Zhang, X., Lauritzen, I., Sévalle, J., Moréno, S., Paterlini-Bréchot, P., Trebak, M., Checler, F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0875-12.2012 · Cited by 245 · see citing works

Amyloid- Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3 in Primary Cultured Hippocampal Neurons

Decker, H., Lo, K. Y., Unger, S. M., Ferreira, S. T., & Silverman, M. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1074-10.2010 · Cited by 216 · see citing works

Calcineurin in memory and bidirectional plasticity

Mansuy, I. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.046 · Cited by 201 · see citing works

Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan

Rothman, S. M., & Mattson, M. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.014 · Cited by 183 · see citing works

N ‐Methyl‐ d ‐aspartate receptors are required for synaptic targeting of Alzheimer’s toxic amyloid‐β peptide oligomers

Decker, H., Jürgensen, S., Adrover, M. F., Brito‐Moreira, J., Bomfim, T. R., Klein, W. L., Epstein, A. L., Felice, F. G. D., Jerusalinsky, D. A., & Ferreira, S. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07058.x · Cited by 164 · see citing works

Activity-Dependent Dendritic Release of BDNF and Biological Consequences

Kuczewski, N., Porcher, C., Leßmann, V., Medina, I., & Gaïarsa, J. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8050-7 · Cited by 158 · see citing works

KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons

Lo, K. Y., Kuzmin, A., Unger, S. M., Petersen, J. D., & Silverman, M. A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.018 · Cited by 155 · see citing works

Aging brain microenvironment decreases hippocampal neurogenesis through Wnt‐mediated survivin signaling

Miranda, C. J., Braun, L., Jiang, Y., Hester, M. E., Zhang, L., Riolo, M., Wang, H., Rao, M., Altura, R. A., & Kaspar, B. K. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00816.x · Cited by 150 · see citing works

Molecular Motor KIF17 Is Fundamental for Memory and Learning via Differential Support of Synaptic NR2A/2B Levels

Yin, X., Takei, Y., Kido, M. A., & Hirokawa, N. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.049 · Cited by 136 · see citing works

Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca 2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF

Paula-Lima, A. C., Adasme, T., SanMartín, C. D., Sebollela, A. S., Hetz, C. A., Carrasco, M. A., Ferreira, S. T., & Hidalgo, C. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3287 · Cited by 136 · see citing works

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipine

Anekonda, T. S., & Quinn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.013 · Cited by 136 · see citing works

Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease

Chakroborty, S., Briggs, C. A., Miller, M. B., Goussakov, I. V., Schneider, C., Kim, J. S., Wicks, J. M., Richardson, J. C., Conklin, V., Cameransi, B. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052056 · Cited by 136 · see citing works

Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1

Lazarov, O., Morfini, G. A., Pigino, G. F., Gadadhar, A., Chen, X., Robinson, J., Ho, H., Brady, S. T., & Sisodia, S. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4272-06.2007 · Cited by 135 · see citing works

A Role for Calcineurin in Alzheimers Disease

Reese, L. C., & Taglialatela, G. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376316 · Cited by 131 · see citing works

Enhanced Ryanodine‐Mediated Calcium Release in Mutant PS1‐Expressing Alzheimer's Mouse Models

Stutzmann, G. E., Smith, I. F., Caccamo, A., Oddo, S., Parker, I., & LaFerla, F. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.025 · Cited by 118 · see citing works

The dendritic hypothesis for Alzheimer's disease pathophysiology

Cochran, J. N., Hall, A. M., & Roberson, E. D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.004 · Cited by 114 · see citing works

Soluble Aβ oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain

Kokubo, H., Kayed, R., Glabe, C. G., & Yamaguchi, H. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.041 · Cited by 110 · see citing works

Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity

Welzel, A. T., Maggio, J. E., Shankar, G. M., Walker, D., Ostaszewski, B. L., Li, S., Klyubin, I. V., Rowan, M. J., Seubert, P. A., Walsh, D. M., et al. (2014) · Biochemistry · doi:10.1021/bi5003053 · Cited by 97 · see citing works

The Sphingolipid Psychosine Inhibits Fast Axonal Transport in Krabbe Disease by Activation of GSK3 and Deregulation of Molecular Motors

Cantuti‐Castelvetri, L., Givogri, M. I., Hebert, A., Smith, B., Song, Y., Kamińska, A., Lopez‐Rosas, A., Morfini, G. A., Pigino, G. F., Sands, M. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0217-13.2013 · Cited by 88 · see citing works

Modulation of Ca2+ channel currents in primary cultures of rat cortical neurones by amyloid β protein (1–40) is dependent on solubility status

Ramsden, M., Henderson, Z., & Pearson, H. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03547-3 · Cited by 87 · see citing works

Distinct Roles for Somatically and Dendritically Synthesized Brain-Derived Neurotrophic Factor in Morphogenesis of Dendritic Spines

Orefice, L. L., Waterhouse, E. G., Partridge, J. G., Lalchandani, R. R., Vicini, S., & Xu, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0012-13.2013 · Cited by 87 · see citing works

Characterization of the Movement of the Kinesin Motor KIF1A in Living Cultured Neurons

Lee, J.-R., Shin, H., Ko, J., Choi, J., Lee, H., & Kim, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211152200 · Cited by 80 · see citing works

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease

Pineda, J. R., Pardo, R., Zala, D., Yu, H., Humbert, S., & Saudou, F. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-33 · Cited by 76 · see citing works

In Vivo Neuron‐Wide Analysis of Synaptic Vesicle Precursor Trafficking

Maeder, C. I., San‐Miguel, A., Wu, E. Y., Lu, H., & Shen, K. (2013) · Traffic · doi:10.1111/tra.12142 · Cited by 75 · see citing works

Subcellular distribution of L-type calcium channel subtypes in rat hippocampal neurons

Leitch, B., Szostek, A., Lin, R. C. S., & Shevtsova, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.006 · Cited by 73 · see citing works

Amyloid precursor protein-induced axonopathies are independent of amyloid-β peptides

Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., Lillo, C., Mount, S. L., Roberts, E. A., McGowan, E., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn240 · Cited by 72 · cited 1× · see citing works

Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons

Ramser, E. M., Gan, K. J., Decker, H., Fan, E. Y., Suzuki, M. M., Ferreira, S. T., & Silverman, M. A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0858 · Cited by 71 · see citing works

Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction

Chakroborty, S., & Stutzmann, G. E. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4205-7 · Cited by 70 · see citing works

Axonal transport and neurodegenerative disease: Can we see the elephant?

Goldstein, L. S. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.006 · Cited by 67 · see citing works

Use-dependent amplification of presynaptic Ca 2+ signaling by axonal ryanodine receptors at the hippocampal mossy fiber synapse

Shimizu, H., Fukaya, M., Yamasaki, M., Watanabe, M., Manabe, T., & Kamiya, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802175105 · Cited by 62 · see citing works

Distinct Dendritic Spine and Nuclear Phases of Calcineurin Activation after Exposure to Amyloid-β Revealed by a Novel Fluorescence Resonance Energy Transfer Assay

Wu, H.-Y., Hudry, E., Hashimoto, T., Uemura, K., Fan, Z., Berezovska, O., Grosskreutz, C. L., Bacskai, B. J., & Hyman, B. T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0227-12.2012 · Cited by 60 · see citing works

Endogenous GSK ‐3/Shaggy Regulates Bidirectional Axonal Transport of the Amyloid Precursor Protein

Weaver, C. I., Leidel, C., Szpankowski, L., Farley, N. M., Shubeita, G. T., & Goldstein, L. S. B. (2012) · Traffic · doi:10.1111/tra.12037 · Cited by 54 · see citing works

Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of β Site Amyloid Precursor Protein-cleaving Enzyme 1

Deng, M., He, W., Tan, Y., Han, H., Hu, X., Xia, K., Zhang, Z., & Yan, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480079 · Cited by 53 · see citing works

In vivo imaging of axonal transport using MRI: aging and Alzheimer’s disease

Minoshima, S., & Cross, D. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0707-8 · Cited by 53 · see citing works

Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport

Dolma, K., Iacobucci, G. J., Zheng, K. H., Shandilya, J., Toska, E., White, J. A., Spina, E., & Gunawardena, S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt505 · Cited by 48 · see citing works

Part of membrane-bound Aβ exists in rafts within senile plaques in Tg2576 mouse brain

Kokubo, H., Saido, T. C., Iwata, N., Helms, J. B., Shinohara, R., & Yamaguchi, H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.04.008 · Cited by 47 · see citing works

Incubation of nerve endings with a physiological concentration of Aβ1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release

Bobich, J. A., Zheng, Q., & Campbell, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6305 · Cited by 46 · see citing works

The Kinesin-3, Unc-104 Regulates Dendrite Morphogenesis and Synaptic Development in Drosophila

Kern, J. V., Zhang, Y. V., Krämer, S., Brenman, J. E., & Rasse, T. M. (2013) · Genetics · doi:10.1534/genetics.113.151639 · Cited by 46 · see citing works

A translational continuum of model systems for evaluating treatment strategies in Alzheimer’s disease: isradipine as a candidate drug

Copenhaver, P. F., Anekonda, T. S., Musashe, D. T., Robinson, K. M., Ramaker, J. M., Swanson, T. L., Wadsworth, T. L., Kretzschmar, D., Woltjer, R. L., & Quinn, J. F. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006841 · Cited by 44 · see citing works

The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases

Cataldi, M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030004 · Cited by 44 · see citing works

Presynaptic Ryanodine Receptor–CamKII Signaling is Required for Activity-dependent Capture of Transiting Vesicles

Wong, M. Y., Shakiryanova, D. M., & Levitan, E. S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9080-8 · Cited by 39 · see citing works

A Myosin Va Mutant Mouse with Disruptions in Glutamate Synaptic Development and Mature Plasticity in Visual Cortex

Yoshii, A., Zhao, J.-P., Pandian, S., van Zundert, B., & Constantine‐Paton, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4585-12.2013 · Cited by 38 · see citing works

Nebula/DSCR1 Upregulation Delays Neurodegeneration and Protects against APP-Induced Axonal Transport Defects by Restoring Calcineurin and GSK-3β Signaling

Shaw, J. L., & Chang, K. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003792 · Cited by 38 · see citing works

Vesicle capture, not delivery, scales up neuropeptide storage in neuroendocrine terminals

Bulgari, D., Zhou, C., Hewes, R. S., Deitcher, D. L., & Levitan, E. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322170111 · Cited by 34 · see citing works

R-flurbiprofen improves axonal transport in the Tg2576 mouse model of Alzheimer's Disease as determined by MEMRI

Smith, K. D. B., Paylor, R. E., & Pautler, R. G. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22733 · Cited by 32 · see citing works

Synthetic Aβ oligomers (Aβ1–42 globulomer) modulate presynaptic calcium currents: Prevention of Aβ-induced synaptic deficits by calcium channel blockers

Hermann, D. J., Mezler, M., Müller, M., Wicke, K. M., Groß, G., Draguhn, A., Bruehl, C., & Nimmrich, V. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.030 · Cited by 31 · see citing works

Real-Time Imaging of the Dynamics of Secretory Granules in Growth Cones

Abney, J. R., Meliza, C. D., Cutler, B., Kingma, M., Lochner, J. E., & Scalettar, B. A. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77120-1 · Cited by 26 · see citing works

Intracellular Transport: The Causes for Pauses

Trybus, K. M. (2013) · Current Biology · doi:10.1016/j.cub.2013.06.005 · Cited by 11 · see citing works

Live Imaging of Dense-core Vesicles in Primary Cultured Hippocampal Neurons

Kwinter, D. M., & Silverman, M. A. (2009) · Journal of Visualized Experiments · doi:10.3791/1144 · Cited by 10 · see citing works

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer’s disease

Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373 · see citing works

Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases

Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 355 · see citing works

Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies

Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258 · see citing works

The Toxicity and Polymorphism of β-Amyloid Oligomers

Huang, Y., & Liu, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124477 · Cited by 168 · see citing works

Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?

Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150 · see citing works

Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies

Tejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126 · see citing works

Unfolding the Role of BDNF as a Biomarker for Treatment of Depression

Rana, T., Behl, T., Sehgal, A., Srivastava, P., & BUNGAU, S. G. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01754-x · Cited by 127 · see citing works

The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases

Kipanyula, M. J., Kimaro, W. H., & Etet, P. F. S. (2016) · Journal of Aging Research · doi:10.1155/2016/5081021 · Cited by 112 · see citing works

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?

Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70 · see citing works

Intracellular amyloid β oligomers impair organelle transport and induce dendritic spine loss in primary neurons

Umeda, T., Ramser, E. M., Yamashita, M., Nakajima, K., Mori, H., Silverman, M. A., & Tomiyama, T. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0230-2 · Cited by 63 · see citing works

The relationship between adult hippocampal neurogenesis and cognitive impairment in Alzheimer's disease

Geigenmüller, J. N., Tari, A. R., Wisløff, U., & Walker, T. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14179 · Cited by 64 · see citing works

Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders

Sharma, V., Singh, T. G., Kaur, A., Mannan, A., & Dhiman, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03755-1 · Cited by 55 · see citing works

Brothers in Arms: ProBDNF/BDNF and sAPPα/Aβ-Signaling and Their Common Interplay with ADAM10, TrkB, p75NTR, Sortilin, and sorLA in the Progression of Alzheimer’s Disease

Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46 · see citing works

A central role for calcineurin in protein misfolding neurodegenerative diseases

Shah, S. Z. A., Hussain, T. A., Zhao, D., & Yang, L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2379-7 · Cited by 46 · see citing works

Targeting CaN/NFAT in Alzheimer’s brain degeneration

Mackiewicz, J., Lisek, M., & Boczek, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281882 · Cited by 40 · see citing works

When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer’s Disease

Agostini, M., & Fasolato, C. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.06.008 · Cited by 38 · see citing works

Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease

Tremblay, G., Rousseau, J., Mbakam, C. H., & Tremblay, J. P. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0085 · Cited by 37 · see citing works

Factors affecting the GABAergic synapse function in Alzheimer’s disease: Focus on microRNAs

Rivera, J., Sharma, B., Torres, M. M., & Kumar, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102123 · Cited by 36 · see citing works

Multi-site dynamic recording for Aβ oligomers-induced Alzheimer's disease in vitro based on neuronal network chip

Gao, F., Gao, K., He, C., Liu, M., Wan, H., & Wang, P. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.03.025 · Cited by 33 · see citing works

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

Wang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecı̀ć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32 · see citing works

The Role of Synaptic Dysfunction in Alzheimer’s Disease

Pei, Y. A., Davies, J., Zhang, M., & Zhang, H. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191334 · Cited by 28 · see citing works

Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View

Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 27 · see citing works

Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease

Sun, L., & Wei, H. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00936-w · Cited by 22 · see citing works

GSK3β Impairs KIF1A Transport in a Cellular Model of Alzheimer’s Disease but Does Not Regulate Motor Motility at S402

Gan, K. J., Akram, A., Blasius, T. L., Ramser, E. M., Budaitis, B. G., Gabrych, D. R., Verhey, K. J., & Silverman, M. A. (2020) · eNeuro · doi:10.1523/eneuro.0176-20.2020 · Cited by 16 · see citing works

Neuroprotective activity of Ulmus pumila L. in Alzheimer's disease in rats; role of neurotrophic factors

Hussein, R. A., Afifi, A. H., Soliman, A. A. F., Elshahid, Z. A., Zoheir, K. M. A., & Mahmoud, K. M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05678 · Cited by 17 · see citing works

Amyloid-β Impairs Vesicular Secretion in Neuronal and Astrocyte Peptidergic Transmission

Plá, V., Barranco, N., Pozas, E., & Aguado, F. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00202 · Cited by 13 · see citing works

BDNF trafficking and signaling impairment during early neurodegeneration is prevented by moderate physical activity

de Almeida, M. F., Chaves, R. S., Silva, C. M., Chaves, J. C. S., de Melo, K. P., & Ferrari, M. (2016) · IBRO Reports · doi:10.1016/j.ibror.2016.08.001 · Cited by 14 · see citing works

β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

O'connell, A., Quinlan, L. R., & Kwakowsky, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107436 · Cited by 12 · see citing works

Imaging Intracellular Trafficking in Neurons of C. elegans

Nadiminti, S. S. P., & Koushika, S. P. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1990-2_27 · Cited by 8 · see citing works

Modeling the neuron as a nanocommunication system to identify spatiotemporal molecular events in neurodegenerative disease

Banerjee, A., Paluh, J. L., Mukherjee, A., Kumar, K. G., Ghosh, A., & Naskar, M. K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152664 · Cited by 8 · see citing works

Imaging organelle transport in primary hippocampal neurons treated with amyloid-β oligomers

Gan, K. J., & Silverman, M. A. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2015.06.012 · Cited by 7 · see citing works

Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?

Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6 · see citing works

Neuroprotective Strategies for Alzheimer’s Disease Prevention and Therapy

Simmons, D. A., Yang, T., Massa, S. M., & Longo, F. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00016-2 · Cited by 6 · see citing works

Gastrodia elata blume (Gastrodiae Rhizoma, Tianma) extract for cognitive enhancement in middle-aged adults with normal or mild impairment: A randomized, double-blind, placebo-controlled clinical trial

Jun, H., Lee, J., Park, B. O., Kim, R. W., Leem, J., & Kwon, K. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106942 · Cited by 3 · see citing works

Vesicular Transport and Amyloids: The Growing Relationship

Upadhyay, A. (2024) · Biologics · doi:10.3390/biologics4040023 · Cited by 1 · see citing works

Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease

Khan, S. A., Raza, K., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1676065 · Cited by 1 · see citing works

The Role of Ryanodine Receptor 2 in Drug-Associated LearningPreprint

Barber, K. R., Vizcarra, V. S., Zilch, A., Majuta, L. A., Diezel, C. C., Culver, O. P., Hughes, B. W., Taniguchi, M., Streicher, J. M., Vanderah, T. W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.03.560743

Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease

Jiang, N. (2019) · theses.fr (ABES) · doi:10.70675/e788b268zc8e3z491az8d02z52080880e988

Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies

Barbereau, C. (2020) · theses.fr (ABES) · doi:10.70675/dfe1802ez70f2z4da6zb3e5z63d1de7a429c

Dysregulation of neuronal calcium signaling impairs axonal transport independent of tau in a model of Alzheimer's disease

Gan, K. J. (2014) · Summit (Simon Fraser University)

Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons

Ramser, E. M., Gan, K. J., Decker, H., Fan, E. Y., Suzuki, M. M., Ferreira, S. T., & Silverman, M. A. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-12-0858 · Cited by 71 · see citing works

P4‐290: Calcineurin disrupts fast axonal transport independently of tau in beta‐amyloid oligomer‐treated hippocampal neurons

Gan, K. J., & Silverman, M. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.08.071

2494 | E. M. Ramser and K. J. Gan et al. Molecular Biology of the Cell

Article, M., Ferreirac, S. T., & Silvermana, M. A. (2016)

Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta

Pigino, G. F., Morfini, G. A., Atagi, Y., Deshpande, A., Yu, C., Jungbauer, L. M., LaDu, M. J., Busciglio, J. A., & Brady, S. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901229106 · Cited by 226 · see citing works